Satori Pharmaceuticals Shuts Down After Alzheimer Trial Failure
5/31/2013 9:30:25 AM
More...
|
Data Underscore Promise of Satori Pharmaceuticals' Gamma-Secretase Modulator Program in Treatment of Alzheimer's Disease
7/19/2012 10:19:09 AM
More...
|
Satori Pharmaceuticals to Present Data Highlighting Promise of Gamma-Secretase Modulators in Treatment of Alzheimer's Disease
7/11/2012 10:42:07 AM
More...
|
Satori Pharmaceuticals Raises $15 Million in New Funding
2/23/2012 6:50:36 AM
More...
|
Satori Pharmaceuticals Demonstrates its Approach to Modulating Gamma-Secretase Effective In Reducing Plaque-Forming Amyloid Beta Peptide
7/18/2011 6:05:17 AM
More...
|
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team; Steven Holtzman Elected Chair of the Board of Directors; Jeff Jonker Appointed Chief Business Officer
4/27/2010 3:33:32 PM
More...
|
Steven Holtzman Joins Satori Pharmaceuticals Board of Directors
9/3/2009 12:01:16 PM
More...
|
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
1/8/2009 6:34:10 AM
More...
|